Form 4 for MGNX MACROGENICS INC
Accepted 2021-11-16 00:00:00 ET · period of report 2021-11-16 · accession 0001125345-21-000117 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-16 | 2021-11-16 | MGNX | Bonvini Ezio | SVP, CSO, Research | M - OptEx | $16.00 | +2,540 | 111.1K | +2% | +$40.6K |
| D | 2021-11-16 | 2021-11-16 | MGNX | Bonvini Ezio | SVP, CSO, Research | M - OptEx | $0.00 | -2,540 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-16 | M | A | 2,540 | $16.00 | 111,090 | D | — | — | |
| 2 | Derivative | Employee stock option (right to buy) | 2021-11-16 | M | D | 2,540 | $0.00 | 0 | D | $16.00 · 2014-04-09 to 2023-10-09 | 2,540 Common Stock | (F1) 12.5% of the shares underlying the grant became exercisable on the date reflected and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter. |